Page 7 - Geron Corporation Nasdaq News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Geron Corporation Reports Business Highlights and Third Quarter 2023 Financial Results

Imetelstat is currently under regulatory review by the FDA and EMA for the treatment of transfusion-dependent anemia in adult patients with lower risk MDS Planning is ongoing for a potential.

United statesJohna scarlettGeron corporation nasdaqSociety of hematologic oncology annual meetingMomenta pharmaceuticals incDrug administrationSafety evaluation teamEuropean unionAmerican society of hematologyEuropean medicines agencyUs food drug administrationExchange commissionGeron corporationChief executiveNew drug applicationPrescription drug user fee act

Geron IMerge Phase 3 Presentations at Upcoming ASH Annual Meeting Reinforce Significant Durability and Breadth of Effect of Imetelstat in Lower Risk MDS

Geron IMerge Phase 3 Presentations at Upcoming ASH Annual Meeting Reinforce Significant Durability and Breadth of Effect of Imetelstat in Lower Risk MDS
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

United statesSan diegoOptum clinformaticsFaye fellerEuropean medicines agencyEuropean unionGeron corporation nasdaqDrug administrationInternational prognostic scoring systemMoffitt cancer centerExchange commissionMalignant hematology departmentAmerican society of hematologyLarge us health insurance claims databaseMeeting reinforce significant durabilityLower risk

Geron to Announce Third Quarter 2023 Financial Results on November 2, 2023

Geron to Announce Third Quarter 2023 Financial Results on November 2, 2023
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesKristen kelleherAaron feingoldGeron corporation nasdaqGeron corporationDrug administrationCorporate communicationsNobel prize winningNew drug applicationUnited states foodPrescription drug user fee actMarketing authorization applicationEuropean committeeMedicinal productsHuman useInvestor relations

Geron to Announce Third Quarter 2023 Financial Results on November 2, 2023

Geron to Announce Third Quarter 2023 Financial Results on November 2, 2023
eagletribune.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eagletribune.com Daily Mail and Mail on Sunday newspapers.

United statesAaron feingoldCommunicationskristen kelleherGeron corporation nasdaqDrug administrationGeron corporationNobel prize winningNew drug applicationUnited states foodPrescription drug user fee actMarketing authorization applicationEuropean committeeMedicinal productsHuman useInvestor relationsCorporate communicationskristen

Geron to Announce Third Quarter 2023 Financial Results on November 2, 2023

Geron Corporation , a late-stage clinical biopharmaceutical company, today announced that it will release its third quarter 2023 financial results and business highlights before the market opens on.

United statesDrug administrationGeron corporation nasdaqGeron corporationNobel prize winningNew drug applicationUnited states foodPrescription drug user fee actMarketing authorization applicationEuropean committeeMedicinal productsHuman use